Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2018
Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1Katherine Walwyn-Brown, Karolin Guldevall, Mezida Saeed, et al.
Cancer Research|December 18, 2004
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interactionRoberta Castriconi, Alessandra Dondero, Maria Valeria Corrias, et al.
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Veterinary Research|September 17, 2009
Ovine CD16+/CD14- blood lymphocytes present all the major characteristics of natural killer cellsJamila Elhmouzi-Younes, Preben Boysen, Daniela Pende, et al.
Blood|June 17, 2006
Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the diseaseStefania Marcenaro, Federico Gallo, Stefania Martini, et al.
Experimental Hematology|September 10, 2014
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cellsRut Valgardsdottir, Cristina Capitanio, Gemma Texido, et al.
Cancer Letters|August 23, 2008
Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cellsMareike Schmudde, André Braun, Daniela Pende, et al.
Immunology Letters|May 18, 2016
Human NK cells: From surface receptors to clinical applicationsLorenzo Moretta, Gabriella Pietra, Paola Vacca, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Oncoimmunology|July 18, 2024
Human NK cells and cancerClaudia Cantoni, Michela Falco, Massimo Vitale, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2018
Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1Katherine Walwyn-Brown, Karolin Guldevall, Mezida Saeed, et al.
Cancer Research|December 18, 2004
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interactionRoberta Castriconi, Alessandra Dondero, Maria Valeria Corrias, et al.
FEBS Letters|May 11, 2011
Human NK receptors: from the molecules to the therapy of high risk leukemiasLorenzo Moretta, Franco Locatelli, Daniela Pende, et al.
Veterinary Research|September 17, 2009
Ovine CD16+/CD14- blood lymphocytes present all the major characteristics of natural killer cellsJamila Elhmouzi-Younes, Preben Boysen, Daniela Pende, et al.
Blood|June 17, 2006
Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the diseaseStefania Marcenaro, Federico Gallo, Stefania Martini, et al.
Experimental Hematology|September 10, 2014
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cellsRut Valgardsdottir, Cristina Capitanio, Gemma Texido, et al.
Cancer Letters|August 23, 2008
Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cellsMareike Schmudde, André Braun, Daniela Pende, et al.
Immunology Letters|May 18, 2016
Human NK cells: From surface receptors to clinical applicationsLorenzo Moretta, Gabriella Pietra, Paola Vacca, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Oncoimmunology|July 18, 2024
Human NK cells and cancerClaudia Cantoni, Michela Falco, Massimo Vitale, et al.
Pageof 11